Swift Biosciences Accel-NGS Unique Dual Indexing Kit
Swift Biosciences has announced the release of its Accel-NGS Unique Dual Indexing Kit. Developed in a set of 96 dual indices for both i7 and i5 positions, the indexing kits improve misassignment rates to less than a percent and enable multiple applications including whole-genome sequencing, as well as whole-exome and methylation analysis. In addition, Swift's kits allow a scalable workflow for low-frequency somatic variant discovery, formalin-fixed paraffin-embedded analysis, microbial detection in human samples, and cell-free DNA analysis. The kits are compatible with any Illumina sequencing platform.
MNG Laboratories Actionable Epilepsy Panel
MNG Laboratories has announced the commercial launch of its MNG Xpress Actionable Epilepsy panel, a DNA-sequencing assay that uses a standard capture hybridization method to sequence the coding regions of exons. The panel contains a targeted list of 69 epilepsy and seizure-related genes that the company claims are immediately actionable via seizures, pharmacological interventions, and dietary changes. In addition, the panel has a guaranteed turnaround time of less than two weeks for results.
LifeMap TGex Version 3.0
LifeMap Sciences has introduced version 3.0 of its TGex clinical genomics platform, featuring interpretation and analysis for structural variations based on phenotypes. The new release draws on the LifeMap Sciences GeneCards human gene database to "score" structural variations according to a patient's phenotype, then provides evidence to help with interpreting links between the gene and the phenotype and other associations. The GeneCards VarElect next-generation sequencing phenotyper supports genome-wide analysis of both copy-number variations and single-nucleotide variations, TGex said.
For more new products and services, please visit the New Products page on our website.